Nesfatin-1 attenuates injury in a rat model of myocardial infarction by targeting autophagy, inflammation, and apoptosis

References

• Amani, H., et al., 2019a. Three-dimensional graphene foams: synthesis, properties, biocompatibility, biodegradability, and applications in tissue engineering. ACS biomaterials science & engineering, 5 (1), 193–214.
   PubMed Web of Science ®Google Scholar
• Amani, H., et al., 2019b. Would colloidal gold nanocarriers present an effective diagnosis or treatment for ischemic stroke? International journal of nanomedicine, 14, 8013–8031.
   PubMed Web of Science ®Google Scholar
• Amani, H., et al., 2019c. Controlling cell behavior through the design of biomaterial surfaces: a focus on surface modification techniques. Advanced materials interfaces, 6 (13), 1900572.
   Web of Science ®Google Scholar
• Amani, H., et al., 2019d. Tailoring synthetic polymeric biomaterials towards nerve tissue engineering: a review. Artificial cells, nanomedicine, and biotechnology, 47 (1), 3524–3539.
   PubMed Web of Science ®Google Scholar
• Amani, H., et al., 2019e. Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling. Scientific reports, 9 (1), 1–15.
   PubMedGoogle Scholar
• Angelone, T., et al., 2013. Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injury. Cellular and molecular life sciences, 70 (3), 495–509.
   PubMed Web of Science ®Google Scholar
• Aydin, S., 2013. Multi-functional peptide hormone NUCB2/nesfatin-1. Endocrine, 44 (2), 312–325.
   PubMed Web of Science ®Google Scholar
• Barutcigil, A. and Tasatargil, A., 2018. Effects of nesfatin-1 on atrial contractility and thoracic aorta reactivity in male rats. Clinical and experimental hypertension, 40 (5), 414–420.
   PubMed Web of Science ®Google Scholar
• Chan, P.H., 2004. Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochemical research, 29 (11), 1943–1949.
   PubMed Web of Science ®Google Scholar
• Dai, H., et al., 2013. Decreased plasma nesfatin-1 levels in patients with acute myocardial infarction. Peptides, 46, 167–171.
   PubMed Web of Science ®Google Scholar
• Drum, B., et al., 2016. Oxidative stress in myocardial infarction disrupts microtubule trafficking, reducing transient outward current density. Biophysical journal, 110 (3), 129a.
   Web of Science ®Google Scholar
• Freude, B., et al., 2000. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. Journal of molecular and cellular cardiology, 32 (2), 197–208.
   PubMed Web of Science ®Google Scholar
• Go, A.S., et al., 2014. Executive summary: heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation, 129 (3), 399–410.
   PubMed Web of Science ®Google Scholar
• Jezek, J., et al., 2019. Mitochondrial translocation of cyclin C stimulates intrinsic apoptosis through Bax recruitment. EMBO reports, 20 (9), e47425.
   PubMed Web of Science ®Google Scholar
• Jiang, G., et al., 2015. The protective effect of nesfatin-1 against renal ischemia-reperfusion injury in rats. Renal failure, 37 (5), 882–889.
   PubMed Web of Science ®Google Scholar
• Kostin, S., et al., 2003. Myocytes die by multiple mechanisms in failing human hearts. Circulation Research, 92 (7), 715–724.
   PubMed Web of Science ®Google Scholar
• Ma, H., et al., 2011. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. European heart journal, 32 (8), 1025–1038.
   PubMed Web of Science ®Google Scholar
• Mehrjerdi, F.Z., et al., 2015. The protective effect of remote renal preconditioning against hippocampal ischemia reperfusion injury: role of KATP channels. Journal of molecular neuroscience, 57 (4), 554–560.
   PubMed Web of Science ®Google Scholar
• Münzel, T., et al., 2015. Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. European heart journal, 36 (38), 2555–2564.
   PubMed Web of Science ®Google Scholar
• Nazarnezhad, S., et al., 2019. Nesfatin-1 protects PC12 cells against high glucose-induced cytotoxicity via inhibiting oxidative stress, autophagy and apoptosis. NeuroToxicology, 74, 196–202.
   PubMed Web of Science ®Google Scholar
• Oh, S., et al., 2006. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature, 443 (7112), 709–712.
   PubMed Web of Science ®Google Scholar
• Pazoki‐Toroudi, H.R., et al., 2010. Pre‐medication and renal pre‐conditioning: a role for alprazolam, atropine, morphine and promethazine. Fundamental & clinical pharmacology, 24 (2), 189–198.
   PubMed Web of Science ®Google Scholar
• Rakhshan, K., et al., 2019. ELABELA (ELA) peptide exerts cardioprotection against myocardial infarction by targeting oxidative stress and the improvement of heart function. International journal of peptide research and therapeutics, 25 (2), 613–621.
   Web of Science ®Google Scholar
• Saporito, F., et al., 2018. In Situ gelling scaffolds loaded with platelet growth factors to improve cardiomyocyte survival after ischemia. ACS biomaterials science & engineering, 5 (1), 329–338.
   PubMed Web of Science ®Google Scholar
• Souri, F., et al., 2019. Natural lavender oil (Lavandula angustifolia) exerts cardioprotective effects against myocardial infarction by targeting inflammation and oxidative stress. Inflammopharmacology, 27 (4), 799–807.
   PubMed Web of Science ®Google Scholar
• Sun, S. and Yang, H., 2018. Tissue-specific localization NUCB2/nesfatin-1 in the liver and heart of mouse fetus. Development & reproduction, 22 (4), 331–339.
   PubMedGoogle Scholar
• Tang, C.-H., et al., 2012. The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain. Peptides, 36 (1), 39–45.
   PubMed Web of Science ®Google Scholar
• Tasatargil, A., et al., 2017. Cardioprotective effect of nesfatin-1 against isoproterenol-induced myocardial infarction in rats: role of the Akt/GSK-3β pathway. Peptides, 95, 1–9.
   PubMed Web of Science ®Google Scholar
• Vinten-Johansen, J., et al., 2007. Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion Injury. Hematology/oncology clinics of North America, 21 (1), 123–145.
   PubMed Web of Science ®Google Scholar
• Wang, H.-W., et al., 2018. Diosgenin protects rats from myocardial inflammatory injury induced by ischemia-reperfusion. Medical science monitor: international medical journal of experimental and clinical research, 24, 246–253.
   PubMed Web of Science ®Google Scholar
• Xu, J., et al., 2015. Mitochondrial JNK activation triggers autophagy and apoptosis and aggravates myocardial injury following ischemia/reperfusion. Biochimica et biophysica acta, 1852 (2), 262–270.
   PubMed Web of Science ®Google Scholar
• Yang, B., et al., 2007. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nature medicine, 13 (4), 486–491.
   PubMed Web of Science ®Google Scholar
• Yosten, G.L. and Samson, W.K., 2009. Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. American journal of physiology. Regulatory, integrative and comparative physiology, 297 (2), R330–R336.
   PubMed Web of Science ®Google Scholar
• Zhang, Y. and Ren, J., 2014. Targeting autophagy for the therapeutic application of histone deacetylase inhibitors in ischemia/reperfusion heart injury. Circulation, 129, 1088–1099.
   PubMed Web of Science ®Google Scholar
• Zhou, L.-Y., et al., 2019. The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathway. Cell death and differentiation, 26 (7), 1299–1315.
   PubMed Web of Science ®Google Scholar